Update in Chronic Obstructive Pulmonary Disease 2019.
作者信息
Alter Peter, Baker Jonathan R, Dauletbaev Nurlan, Donnelly Louise E, Pistenmaa Carrie, Schmeck Bernd, Washko George, Vogelmeier Claus F
机构信息
Department of Medicine, Pulmonary and Critical Care Medicine, Member of the German Center for Lung Research (DZL).
Airway Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2020 Aug 1;202(3):348-355. doi: 10.1164/rccm.202002-0370UP.
Abstract
摘要
相似文献
1
Update in Chronic Obstructive Pulmonary Disease 2019.2019年慢性阻塞性肺疾病的进展
Am J Respir Crit Care Med. 2020 Aug 1;202(3):348-355. doi: 10.1164/rccm.202002-0370UP.
2
Innate immunity and chronic obstructive pulmonary disease: a mini-review.固有免疫与慢性阻塞性肺疾病：小型综述。
Gerontology. 2013;59(6):481-9. doi: 10.1159/000354173. Epub 2013 Sep 3.
3
Biological effect of PM on airway epithelium-focus on obstructive lung diseases.大气细颗粒物（PM）对气道上皮的生物学效应——关注阻塞性肺疾病。
Clin Immunol. 2021 Jun;227:108754. doi: 10.1016/j.clim.2021.108754. Epub 2021 May 6.
4
Alpha-1 Antitrypsin Deficiency Today: New Insights in the Immunological Pathways.今日的α-1抗胰蛋白酶缺乏症：免疫途径的新见解
Respiration. 2016;91(5):380-5. doi: 10.1159/000445692. Epub 2016 May 12.
5
Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells.慢性阻塞性肺疾病患者的肺泡巨噬细胞吞噬凋亡气道上皮细胞的能力不足。
Immunol Cell Biol. 2003 Aug;81(4):289-96. doi: 10.1046/j.1440-1711.2003.t01-1-01170.x.
6
Targeting defective pulmonary innate immunity - A new therapeutic option?靶向缺陷性肺固有免疫——一种新的治疗选择？
Pharmacol Ther. 2020 May;209:107500. doi: 10.1016/j.pharmthera.2020.107500. Epub 2020 Feb 13.
7
The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.巨噬细胞在阻塞性气道疾病中的作用：慢性阻塞性肺疾病和哮喘。
Cytokine. 2013 Dec;64(3):613-25. doi: 10.1016/j.cyto.2013.09.010. Epub 2013 Sep 29.
8
A disintegrin and metalloproteinase domain-15 deficiency leads to exaggerated cigarette smoke-induced chronic obstructive pulmonary disease (COPD)-like disease in mice.ADAM15 缺乏导致小鼠对香烟烟雾诱导的慢性阻塞性肺疾病（COPD）样疾病的反应过度。
Mucosal Immunol. 2021 Mar;14(2):342-356. doi: 10.1038/s41385-020-0325-3. Epub 2020 Jul 20.
9
Cigarette smoke-induced damage-associated molecular pattern release from necrotic neutrophils triggers proinflammatory mediator release.香烟烟雾诱导坏死中性粒细胞释放损伤相关分子模式，触发促炎介质释放。
Am J Respir Cell Mol Biol. 2015 May;52(5):554-62. doi: 10.1165/rcmb.2013-0505OC.
10
Moraxella catarrhalis induces an immune response in the murine lung that is independent of human CEACAM5 expression and long-term smoke exposure.卡他莫拉菌在小鼠肺部诱导免疫反应，该反应独立于人类癌胚抗原相关细胞黏附分子5（CEACAM5）的表达和长期烟雾暴露。
Am J Physiol Lung Cell Mol Physiol. 2015 Aug 1;309(3):L250-61. doi: 10.1152/ajplung.00265.2014. Epub 2015 Jun 5.
引用本文的文献
1
Heart Rate Recovery After Cardiopulmonary Exercise Test Predicts Acute Exacerbations in Patients with Moderate Chronic Obstructive Pulmonary Disease.心肺运动试验后的心率恢复可预测中度慢性阻塞性肺疾病患者的急性加重
Int J Chron Obstruct Pulmon Dis. 2025 May 12;20:1447-1456. doi: 10.2147/COPD.S509504. eCollection 2025.
2
Inequalities in disease burden and care quality of chronic obstructive pulmonary disease, 1990-2021: Findings from the Global Burden of Disease Study 2021.1990-2021 年慢性阻塞性肺疾病疾病负担和护理质量的不平等：2021 年全球疾病负担研究的结果。
J Glob Health. 2024 Sep 27;14:04213. doi: 10.7189/jogh.14.04213.
3
Cigarette Smoke Extract-Treated Mouse Airway Epithelial Cells-Derived Exosomal LncRNA MEG3 Promotes M1 Macrophage Polarization and Pyroptosis in Chronic Obstructive Pulmonary Disease by Upregulating TREM-1 via mA Methylation.香烟烟雾提取物处理的小鼠气道上皮细胞来源的外泌体长链非编码RNA MEG3通过甲基化上调TREM-1促进慢性阻塞性肺疾病中M1巨噬细胞极化和焦亡
Immune Netw. 2024 Jan 19;24(2):e3. doi: 10.4110/in.2024.24.e3. eCollection 2024 Apr.
4
The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases.RAGE轴：人类疾病中一个相关的炎症枢纽。
Biomolecules. 2024 Mar 28;14(4):412. doi: 10.3390/biom14040412.
5
Airway ciliated cells in adult lung homeostasis and COPD.成人肺部稳态和 COPD 中的气道纤毛细胞。
Eur Respir Rev. 2023 Dec 6;32(170). doi: 10.1183/16000617.0106-2023. Print 2023 Dec 31.
6
A Macrophage-Related Gene Signature for Identifying COPD Based on Bioinformatics and ex vivo Experiments.基于生物信息学和体外实验的用于识别慢性阻塞性肺疾病的巨噬细胞相关基因特征
J Inflamm Res. 2023 Nov 29;16:5647-5665. doi: 10.2147/JIR.S438308. eCollection 2023.
7
Comparison of BODE and ADO Indices in Predicting COPD-Related Medical Costs.BODE 和 ADO 指数在预测 COPD 相关医疗费用中的比较。
Medicina (Kaunas). 2023 Mar 15;59(3):577. doi: 10.3390/medicina59030577.
8
Clinical significance of serum levels of 14-3-3β protein in patients with stable chronic obstructive pulmonary disease.慢性阻塞性肺疾病稳定期患者血清 14-3-3β 蛋白水平的临床意义。
Sci Rep. 2023 Mar 24;13(1):4861. doi: 10.1038/s41598-023-32096-4.
9
Adaptation of Nontypeable in Human Airways in COPD: Genome Rearrangements and Modulation of Expression of HMW1 and HMW2.慢性阻塞性肺疾病患者人气道中不可分型流感嗜血杆菌的适应：基因组重排及 HMW1 和 HMW2 表达的调节。
mBio. 2023 Apr 25;14(2):e0014023. doi: 10.1128/mbio.00140-23. Epub 2023 Mar 16.
10
Cardiovascular predictors of mortality and exacerbations in patients with COPD.慢性阻塞性肺疾病患者死亡和加重的心血管预测因素。
Sci Rep. 2022 Dec 19;12(1):21882. doi: 10.1038/s41598-022-25938-0.
本文引用的文献
1
FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema.FSTL-1 衰减导致自发性抗烟雾性肺气肿。
Am J Respir Crit Care Med. 2020 Apr 15;201(8):934-945. doi: 10.1164/rccm.201905-0973OC.
2
Genetics of COPD.COPD 的遗传学。
Annu Rev Physiol. 2020 Feb 10;82:413-431. doi: 10.1146/annurev-physiol-021317-121224. Epub 2019 Nov 15.
3
The Effects of Rare Variants on Lung Function and Emphysema in SPIROMICS.SPIROMICS 中罕见变异对肺功能和肺气肿的影响。
Am J Respir Crit Care Med. 2020 Mar 1;201(5):540-554. doi: 10.1164/rccm.201904-0769OC.
4
Metoprolol for the Prevention of Acute Exacerbations of COPD.美托洛尔预防 COPD 急性加重。
N Engl J Med. 2019 Dec 12;381(24):2304-2314. doi: 10.1056/NEJMoa1908142. Epub 2019 Oct 20.
5
Novel Rare Genetic Variants Associated with Airflow Obstruction in the General Population.与普通人群气流阻塞相关的新型罕见基因变异
Am J Respir Crit Care Med. 2020 Feb 15;201(4):485-488. doi: 10.1164/rccm.201909-1868LE.
6
Long Noncoding Transcriptome in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中的长非编码转录组。
Am J Respir Cell Mol Biol. 2019 Dec;61(6):678-688. doi: 10.1165/rcmb.2019-0184TR.
7
Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease.舒缓紧张气道：针对慢性阻塞性肺疾病的靶向性肺去神经支配术
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1455-1456. doi: 10.1164/rccm.201908-1586ED.
8
Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function.长期暴露于环境空气污染与定量评估的肺气肿和肺功能变化之间的关联。
JAMA. 2019 Aug 13;322(6):546-556. doi: 10.1001/jama.2019.10255.
9
A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.一种新的支气管扩张剂反应分级策略可识别不同的患者群体。
Ann Am Thorac Soc. 2019 Dec;16(12):1504-1517. doi: 10.1513/AnnalsATS.201901-030OC.
10
Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.靶向肺去神经术治疗有症状的中重度慢性阻塞性肺疾病（AIRFLOW）的安全性和不良事件。一项多中心随机对照临床试验。
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1477-1486. doi: 10.1164/rccm.201903-0624OC.
Zotero 插件